Skip to main content
Figure 1 | Biomarker Research

Figure 1

From: Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia

Figure 1

Kaplan-Meier curves of OS, IDH2 codon 140. (A) Significant differences in OS between IDH2 codon 140 genotypes in intermediate risk AML patients. Median OS 6 vs. 18 months (p < 0.001) for IDH2 codon 140 mutated patients and wild-type patients, respectively. (B) OS for AML-patients with mutated or unmutated IDH2 codon 140 in the entire group, median OS 9 vs. 14 months, respectively (p = 0.278).

Back to article page